Pediatrics

Results of a 16-week trial of insulin aspart

Bristol-Myers Squibb granted approval for arthritis biologic Orencia.

GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.

The FDA is undertaking a study of Merck?s Singulair to see if it is associated with a higher rate of suicide.

Mifamurtide available through compassionate access study

Study shows most adults use non-prescription medications for themselves and their children

Daptacel vaccine gets approved for fifth dose of DTaP

Health Resources & Services Administration launches poison help campaign

FDA issues warning on Tussionex use

National Autism Association holds press conference on mercury-containing vaccines and examine immunization schedule for risk.

Adalimumab approved for polyarticular juvenile idiopathic arthritis.

A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.

Aripiprazole approved for new indication.

Esomeprazole approved for children.

The Centers for Disease Control & Prevention recommends influenza vaccine for all children six months to 18 years old.

Novartis has received final approval for its combination product, Exforge, used to treat hypertension.

America?s pharmaceutical research companies, YMCA of the USA, and Easter Seals have joined forces to help uninsured children access health care.

According to a recent statement released by the American Academy of Pediatrics (AAP), the low reimbursement rates from insurance companies to providers for the cost of providing vaccines to children is a risk to their health.

Pediatric patients are disproportionately affected by improper and wrong-dose errors in perioperative settings.